Left ventricular dysfunction and remodeling in streptozotocin-induced diabetic rats

Circulation Journal

Volumn 70, Issue 3, 2006, Pages 327-334

  Nemoto, Osamu ^a   Kawaguchi, Michiko ^a   Yaoita, Hiroyuki ^a   Miyake, Katsuya ^a   Maehara, Kazuhira ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Actin filament; Cardiomyocyte; Diabetic cardiomyopathy; Left ventricular systolic dysfunction; Streptozotocin induced diabetic rats

Indexed keywords

DOBUTAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; HEART LEFT VENTRICLE FAILURE; HEMODYNAMICS; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DOBUTAMINE; ECHOCARDIOGRAPHY; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HISTOCYTOCHEMISTRY; MALE; MICROFILAMENTS; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MYOCYTES, CARDIAC; RATS; RATS, INBRED WKY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33644604271     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.70.327     Document Type: Article

References (37)

1. William BK, Marthana H, William PC. Role of diabetes in congestive heart failure: The Framingham Study. Am J Cardiol 1974; 34: 29-34.
2. Ho KKL, Pinsky JL, Kannel WB, Levy D. Epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
3. Kawaguchi M, Techigawara T, Ishihata T, Asakura T, Saito F, Maehara K, et al. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 1997; 12: 267-274.
4. Devereux RB, Roman MJ, Paranicas M, O'Gray MJ, Lee ET, Welty TK. Impact of diabetes on cardiac structure and function: The Strong Heart Study. Circulation 2000; 101: 2271-2276.
5. Natari A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E. Coronary atherosclerosis in Type II diabetes: Angiographic findings and clinical outcome. Diabetologia 2000; 43: 632-641.
6. Hoit BD, Castro C, Bultron G. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail 1999; 5: 324-333.
7. Takeda N, Nakamura I, Hatanaka T, Ohkubo T, Nagano M. Myocardial mechanical and myosin isozyme alterations in streptozotocin-induced rats. Jpn Heart J 1988; 29: 455-463.
8. Akula A, Kota MK, Gopisetty SG, Chitrapu RV, Kalagara M, Kalagara S. Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats. Pharmacol Res 2003; 48: 429-435.
9. Mihm MJ, Seifert JL, Coyle CM, Bauer JA. Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci 2001; 22: 527-542.
10. Irlbeck M, Zimmer HG. Functional responses of the left and right heart of diabetic rats to alpha- and beta- adrenergic receptor stimulation. Diabetes Res Clin Pract 1996; 31: S79- S86.
11. Yaoita H, Sakabe A, Maehara K, Maruyama Y. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation 2002; 106: 975-980.
12. Saito F, Kawaguchi M, Izumida J, Asakura T, Maehara K, Maruyama Y. Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats. Diabetologia 2003; 46: 1161-1169.
13. Grover MH, Osvaido AA. Measurement of cardiac size, chamber and valve orifices at autopsy. Hopkins Med J 1973; 133: 96-106.
14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
15. Nutter DO, Nurray TG, Heymsfield SB, Fuller EO. The effect of chronic protein-calorie undernutrition in the rat on myocardial function and cardiac function. Circ Res 1979; 45: 144-152.
16. Savabi F, Kirsch A. Diabetic type of cardiomyopathy in food restricted rats. Can J Physiol Pharm 1992; 70: 1040-1047.
17. Rodrigues B, Cam MC, McNeil JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998; 180: 53-57.
18. Ortola VF, Ballermann JB, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats (Potential mediator of hyperfiltration). J Clin Invest 1987; 80: 670-674.
19. Grunwald JE, DuPont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 1996; 80: 327-331.
20. Rosen P, Ballhausen T, Block W, Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: Influence of tocopherol as antioxidant. Diabetologia 1995; 38: 1157-1168.
21. Standl E, Schnell O. A new look at the heart in diabetes mellitus: From ailing to failing. Diabetologia 2000; 43: 1455-1469.
22. Warley A, Powell JM, Skepper JN. Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats. Diabetologia 1995; 38: 413-421.
23. Roth DA, White CD, Hamilton CD, Hall JL, Stanley WC. Adrenergic desensitization in left ventricle from streptozotocin diabetic swine. J Mol Cell Cardiol 1995; 27: 2315-2325.
24. Fein FS, Cho S, Zola BE, Miller B, Factor SM. Cardiac pathology in the hypertensive diabetic rat. Biventricular damage with right ventricular predominance Am J Pathol 1989; 134: 1159-1166.
25. Regan TJ, Wu CF, Yeh CK, Oldewurtel HA, Haider B. Myocardial composition and function in diabetes: The effect of chronic insulin use. Circ Res 1981; 49: 1268-1277.
26. Riva E, Andreoni G, Bianch R, Latini R, Luvara G, Jeremic G, et al. Changes in diastolic function and hypertensive rats with long-term streptozotocin-induced diabetes. Pharmacol Res 1998; 37: 233-240.
27. Shimizu M, Umeda K, Sugishita N, Yoshio H, Ino H, Takeda R, et al. Collagen remodeling in myocardia of patients with diabetes. J Clin Pathol 1993; 46: 32-36.
28. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu H, Hosomi N, et al. Alteration of left ventricular diastolic filling of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000; 101: 899-907.
29. Golfman L, Dixon IM, Takeda N. Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes. Mol Cell Biochem 1999; 20: 15-25.
30. Malhotra A, Sanghi V. Regulation of contractile proteins in diabetic heart. Cardiovasc Res 1997; 34: 34-40.
31. Tsakirids T, Tong P, Matthews B, Tsiani E, Bilan PJ, Klip A, et al. Role of the actin cytoskeketon in insulin action. Microsc Res Tech 1999; 47: 79-92.
32. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280: 750-752.
33. Young LH, Dahl DM. Physiological hyperinsulinemia inhibits myocardial protein degradation in vivo in the canine heart. Circ Res 1992; 71: 393-400.
34. Mokhtar N, Lavioe LP, Rosseau MS, Nadeau A. Physical training reverses defect in mitocondrial energy production in heart of chronically diabetic rats. Diabetes 1993; 42: 682-687.
35. Giaconelli F, Skazo L, Weirer J. Lysosomal enzyme in experimental diabetic cardiopathy. Clin Biochem 1980; 13: 227-231.
36. Howarth FC, Qureshi MA, Lawrence P, Adeghate E. Chronic effects of streptozotocin-induced diabetes on the ultrastructure of rat ventricular and papillary muscle. Acta Diabetol 2000; 37: 119-124.
37. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, et al. streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 2000; 32: 985-996.